Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Mar 22, 2017 8:00 am EDT

OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder

Mar 14, 2017 8:30 am EDT

OPKO Health's GeneDx to have Significant Presence at ACMG 2017

Mar 14, 2017 8:00 am EDT

OPKO Health to Participate in the Barclays Global Healthcare Conference

Mar 8, 2017 8:00 am EST

OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder

Mar 7, 2017 8:00 am EST

OPKO Subsidiary GenPath Women’s Health Announces the Availability of ClariTest™

Mar 3, 2017 8:00 am EST

OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development

Mar 1, 2017 4:13 pm EST

OPKO Health Reports 2016 Financial and Operating Results

Feb 28, 2017 9:30 am EST

OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day

Feb 27, 2017 4:15 pm EST

OPKO Health to Announce 2016 Fourth Quarter Financial Results on March 1, 2017

Feb 21, 2017 5:18 pm EST

OPKO Health to Participate at Upcoming Healthcare Investment Conferences